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Dental pulp stem cells (DPSCs) have the capacity to give rise to cells with neuronal-
like phenotypes, suggesting their use in brain cell therapies. In the present work, we
wanted to address the phenotypic fate of adult genetically unmodified human DPSCs
cultured in NeurocultTM (Stem Cell Technologies), a cell culture medium without serum
which can be alternatively supplemented for the expansion and/or differentiation of adult
neural stem cells (NSCs). Our results show that non-genetically modified human adult
DPSCs cultured with Neurocult NS-A proliferation supplement generated neurosphere-
like dentospheres expressing the NSC markers Nestin and glial fibrillary acidic protein
(GFAP), but also the vascular endothelial cell marker CD31. Remarkably, 1 month
after intracranial graft into athymic nude mice, human CD31+/CD146+ and Nestin+
DPSC-derived cells were found tightly associated with both the endothelial and pericyte
layers of brain vasculature, forming full blood vessels of human origin which showed
an increased laminin staining. These results are the first demonstration that DPSC-
derived cells contributed to the generation of neovasculature within brain tissue, and
that Neurocult and other related serum-free cell culture media may constitute a fast and
efficient way to obtain endothelial cells from human DPSCs.
Keywords: DPSCs, stereotaxia, endothelial, cell survival, nude mice, regenerative medicine
INTRODUCTION
The dental pulp is home to an active population of neural crest stem cells, which are responsible of
renewing adult differentiated cells, such as odontoblastic cells and Schwann cells, within the pulp
tissue (Kaukua et al., 2014; Aurrekoetxea et al., 2015). These cells are referred to as dental pulp
stem cells (DPSCs) when extracted from permanent teeth, and as stem cells from human exfoliated
deciduous teeth (SHEDs) when extracted from first generation teeth during childhood (Gronthos
et al., 2000, 2002; Miura et al., 2003). Periodontal tissues also harbor different sources of stem cells
with related characteristics (Marrelli et al., 2015; Chen and Liu, 2016; Avinash et al., 2017). All
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the aforementioned cell populations share stemness properties
(Gronthos et al., 2000, 2002) and under the appropriate
conditions are able to differentiate into several cell types,
preferentially to those of mesenchymal lineages, like osteoblasts,
chondroblasts, and adipocytes (Gronthos et al., 2002; Laino
et al., 2005). Differentiation of SHEDs and DPSCs toward neural
lineages has also been extensively reported in the literature in
the presence (Zhang J. et al., 2016) or absence of scaffolds (Kim
et al., 2012; Chang et al., 2014; Majumdar et al., 2016), especially
when cells were cultured with DMEM/F-12 or Neurobasal
medium supplemented with B27 and EGF/FGF growth factors
(Widera et al., 2007; Arthur et al., 2008; Bonnamain et al., 2013;
Gervois et al., 2015). However, a large debate remains as to
whether those cells are genuinely neuronal or merely neuronal
marker-expressing cells (neuron-like cells), or whether they can
effectively integrate into the host brain neuronal connectivity
after their graft in vivo.
Interestingly, DPSCs also have the ability to co-differentiate
synergistically to osteoblast and endothelial cell phenotypes
when cultured with fetal bovine serum (FBS)-containing
media (d’Aquino et al., 2007; Hilkens et al., 2017). Despite
the generation of a highly vascularized bone-like tissue
after their subcutaneous graft in vivo (d’Aquino et al.,
2007; Hilkens et al., 2017), the possibility to use of DPSCs
as a source of young neovasculature has not yet been
seriously considered with a view to the clinic. One of the
underlying reasons is the need of fetal serum (10–20% FBS +
α-MEM) which makes part of most endothelial differentiation
recipes (d’Aquino et al., 2007; Arthur et al., 2008; Bueno
et al., 2013). Although fetal serum is beneficial for cell
survival and rapid cell expansion, its presence also favors
the differentiation of DPSCs toward osteoblastic/odontoblastic
lineages (Yu et al., 2010; Pisciotta et al., 2012). Moreover, cellular
uptake of serum during in vitro culture might also cause host
allergies and immune reactions against the transplanted cells
(Gregory et al., 2006).
In this study, we explored the possibility to obtain endothelial
cells ready to use for in vivo grafts starting from genetically
unmodified human DPSCs. For this purpose, cells were extracted
and cultured directly with a completely serum-free medium. We
chose a commercial neural stem cell (NSC) growth medium
with the presence of heparin, EGF/FGF growth factors, and
B27 without vitamin A. This proliferation-supplemented culture
medium is routinely used to expand neural stem and brain cancer
stem-like cells. We found that this medium was also supportive
for DPSC expansion, and importantly, it was also permissive
for the generation of endothelial cells (mesoderm), without any
need of scaffolds or the presence of serum. Furthermore, the
addition of the differentiation supplement kit to this culture
medium made DPSCs receptive to in vitro differentiation
toward neuronal and astroglial (neuroectoderm) fates. When
DPSCs were grafted into the brain of immunocompromised
nude mice, they were able to integrate into murine vasculature
differentiating toward endothelial and pericyte lineages without
osteoblast/cartilage production. The clinical relevance is major,
because (i) we generated a large endothelial cell population
out of free floating DPSC dentospheres and (ii) we did not
use fetal serum, which is known to be highly allergenic and
responsible for the rejection of cell transplants in humans
(Gregory et al., 2006).
MATERIALS AND METHODS
Cell Culture and Cell Proliferation
Human third molars were obtained from healthy donors of
between 19 and 45 years of age. Tooth samples were obtained
by donation after written informed consent in compliance with
the 14/2007 Spanish directive for Biomedical research, and the
protocol was approved by the CEISH committee of UPV/EHU.
DPSC isolation and culture were carried out as previously
reported (Gronthos et al., 2000). Briefly, DPSCs were isolated by
mechanical fracture and enzymatic digestion of the pulp tissue
for 1 h at 37◦C with 3 µg/mL collagenase (17018-029, Thermo
Fisher Scientific, Waltham, MA, United States), and 4 mg/mL
dispase (17105-041, Thermo Fisher Scientific, Waltham, MA,
United States). After centrifugation at 1500 rpm for 5 min, cells
were resuspended and underwent mechanical dissociation by 18-
G needles (304622,BD Microlance 3). Then DPSCs were cultured
in parallel with different types of culture media: (i): DMEM
(Lonza 12-733, Basel, Switzerland) supplemented with 10%
of inactivated FBS (SV30160.03, Hyclone, GE Healthcare Life
Sciences, Logan, UT, United States), 2 mM L-glutamine (G7513,
Sigma, St. Louis, MO, United States), and 100 U/mL penicillin
+ 150 µg/mL streptomycin antibiotics (15140-122, Gibco). (ii):
Human Neurocult medium composed of Human Neurocult NS-
A basal medium (cat# 05750, Stem Cell Technologies, Vancouver,
BC, Canada) with Neurocult proliferation supplement (cat#
05753, Stem Cell Technologies, Vancouver, BC, Canada) or
Neurocult differentiation supplement (cat# 05752, Stem Cell
Technologies, Vancouver, BC, Canada) both at 9:1 ratio, and
supplemented with Heparin solution 2 µg/mL (cat# 07980, Stem
Cell Technologies, Vancouver, BC, Canada), EGF 20 ng/mL,
and FGFb 10 ng/mL (Peprotech, London, United Kingdom) as
previously described (Pineda et al., 2013) in the presence of
antibiotics penicillin 100 U/mL and streptomycin 150 µg/mL
(15140-122, Gibco). For NSC cultures isolated from Nestin-
GFP mice, dissected hippocampi were removed with ice-cooled
PBS-sucrose and processed as SVZ as previously described
(Pineda et al., 2013). Cells were maintained at standard
conditions in a humidified 37◦C incubator containing 5% CO2.
Neurosphere cultures were then passaged every 7 days by
enzymatic disaggregation with Accutase (Sigma, St. Louis, MO,
United States). We cultured DPSCs cells for 1 month and a
maximum of four total passages in order to avoid cell aging issues.
The population doubling (PD) rate was determined by
initial cell culture. Cells, neurospheres, and dentospheres were
disaggregated, counted, and passaged at day 7. At each passage,
cells were re-plated at the initial density and cultures were
performed until passage 4. The PD rate was calculated as
previously described (Pisciotta et al., 2012). All cells were seeded
at the density of 6 × 103 cells/cm2 and cultured for 1 week. Cell
counting was performed after cell detachment or dissociation
using an automated TC20 from Bio-Rad cell counter. The total
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number of cells estimation was calculated on three experimental
samples for each type of culture.
For phospho-STAT3 inhibition experiment on Neurocult
proliferation cultures, 25,000 cells were allowed to attach and
growth as monolayer using a coating of laminin matrix (1:100,
Sigma) during 3 days. Then, Stattic an irreversible Stat3 inhibitor
(S7947, Sigma, St. Louis, MO, United States) was added to
the medium at 0, 1, and 2.5 µM concentration for 72 h as
previously described (Li et al., 2018) and then cells were fixed for
immunofluorescence analysis.
Flow Cytometry
Half-million DPSCs grown in either DMEM 10% FBS or
Neurocult proliferation media were detached, disaggregated, and
then incubated with PBS 0.15% BSA solution with 0.5 µg of
CD31-FITC or IgG2a κ Isotype control (#303103 and #400107,
respectively, BioLegend CS, United States) for 1 h at 4◦C.
After a wash with PBS 0.15% BSA cells were resuspended in
300 µL of PBS 0.15% BSA and analyzed using a FACS Beckman
Coulter Gallios (Beckman Coulter Life Sciences, Indianapolis, IN,
United States). The data were analyzed using Flowing Software
2.5 (University of Turku, Finland).
Animals and Cell Graft
Consanguine c57bl6 litters from Nestin GFP mice and Athymic
Swissnu/nu were used as hosts for murine and human in vivo graft
purposes. Nestin-GFP neurospheres or DPSCs dentospheres
in the active growth phase were disaggregated, washed, and
collected in Neurocult serum-free media. Two microliters
containing 100,000 cells were injected (0.5 µL/min) unilaterally
into the dentate gyrus of the hippocampus at the following
coordinates (from bregma): AP = −1.9, L = −1.2, and DV = −2
and −2.1. The cell transplantations were performed using a
small animal stereotaxic apparatus (Kopf model 900) with a
10 µL Hamilton syringe and a 33-G needle (Hamilton, Bonaduz,
Switzerland). Pre-operatory and post-operatory animal care were
carried out as previously described (Jeitany et al., 2015). Animals
were provided with food and water ad libitum and housed in a
colony isolator maintained at a constant temperature of 19–22◦C
and humidity (40–50%) on a 12:12 h light/dark cycle.
Immunostaining of Brain Sections and
Cell Culture
Animals were deeply anesthetized with Avertin 2.5% and
perfused with a 4% paraformaldehyde solution in 0.1 M sodium
phosphate, pH 7.2, and processed as previously described
(Pineda et al., 2013). In order to detect grafted genetically
unmodified human DPSCs on mice brain, specific antibodies
targeted to human Nestin (MAB1259, 1:200 R&D systems)
(Jeitany et al., 2015), and human CD31 (BBA7, 1:200 R&D
systems) were used. Pericyte staining was performed using
of anti-CD146 (ab75769, 1:150, Abcam). Immunostaining of
brain vasculature was made using CD31 (550247, 1:300 BD
Pharmingen), laminin (L9393, 1:200 Sigma, St. Louis, MO,
United States), and VEGF (ABS82-AF647, 1:200 Sigma, St. Louis,
MO, United States) antibodies. Both NSCs and DPSCs, either
in the form of dissociated cells or small spheres, were seeded
into laminin-treated coverslips (L2020, Sigma, St. Louis, MO,
United States) as previously described (Silvestre et al., 2011).
After 3 days or 1 week, they were fixed by incubation with
4% PFA for 10 min at room temperature and permeabilized
by incubation in 0.1% Triton X-100. They were then incubated
overnight at 4◦C with primary antibodies at the following
dilutions: glial fibrillary acidic protein (GFAP) (MAB3402, 1:400;
Millipore, Lake Placid, NY, United States), Nestin (NES, 1:200
Aves Labs), S100ß (Z0311, 1:1000, Dako, Glostrup, Denmark),
NeuN (EPR12763, 1:200; Abcam, Cambridge, United Kingdom),
doublecortin (DCX) (sc-8066, 1:200; Santa Cruz, Dallas, TX,
United States), CD31 (550247, 1:300 BD Pharmingen, San Jose,
CA, United States), anti-VEGFR (#9698S 1:800, Cell Signaling
Technologies, Danvers, MA, United States) anti-STAT3 (phospho
Y705) antibody (ab76315, 1:500 Abcam), anti-human-CD31
(F8402, 1:200, Sigma St. Louis, MO, United States). For both
tissue sections and cell culture, secondary antibodies conjugated
to Alexa 488, 568, and 647 Donkey anti-mouse, anti-rabbit,
or anti-goat were incubated for 2 h and 30 min, at room
temperature. Preparations were counterstained with DAPI and
images were captured using a Leica SP8 confocal microscope at
40X magnification.
Conventional PCR and Quantitative
Real-Time PCR (QPCR)
RNA extraction from cell pellets, reverse transcription, and
QPCR were performed as previously described (Uribe-Etxebarria
et al., 2017). The molecular weights of the amplification products
were checked by electrophoresis in a 2% agarose gel. All reactions
were performed in triplicate and the relative expression of each
gene was calculated using the standard 2−11Ct method (Livak
and Schmittgen, 2001). GAPDH and β-ACTIN were used as
housekeeper genes. Primer pairs used were obtained through
the Primer-Blast method (Primer Bank) and they are listed in
Supplementary Table S1.
Western Blot
Dental pulp stem cells grown using either Neurocult proliferation
medium or DMEM + 10% FBS and liver sinusoidal endothelial
cells (LSECs) were counted, pelleted, and resuspended in a ratio
of 20,000 cells/µL with RIPA lysis buffer (R0278, Sigma, St. Louis,
MO, United States) supplemented with protease (11873580001;
Roche) and phosphatase inhibitors (78420; Thermo Scientific) in
order to obtain the same cellular concentration for the different
type of cells and culture media. From this, 30 µg of protein were
diluted in a mix of RIPA buffer and LDS Sample Buffer (NP0007;
Invitrogen by Life technologies). Electroblot was performed
as previously described (Jeitany et al., 2015). Phosphorylated-
ERK and total ERK antibodies (both 1:1000, #4370 and #4695,
respectively, Cell Signaling Technologies) and phospho-Stat3 and
Stat3 (both 1:1000, #9145 and #9132, respectively, Cell Signaling
Technologies, Danvers, MA, United States) were used to detect
the angiogenic signaling pathways and Ponceau staining (P7170-
1L, Sigma St. Louis, MO, United States) was used as loading
control to detect protein in the charged lanes.
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Statistical Analysis
Comparisons between multiple groups were made using Kruskal-
Wallis followed by Dunn’s post hoc test. Comparisons between
only two groups were made using U-Mann–Whitney test or
Student’s t-test. p< 0.05 was considered as statistically significant.
Results were presented as mean ± SD or SEM. The number of
independent experiments is shown in the respective section.
Study Approval
The animal experiments were performed in compliance with the
European Communities Council Directive of November 24, 1986
(86/609/EEC) and were approved by the competent authority
(Diputación Foral de Bizkaia).
RESULTS
Comparative Characterization of DPSC
Growth and Neural Stem Marker
Expression Using Neurocult NS-A
Proliferation Medium
Previous research had shown that the dental pulp tissue of adult
teeth contained neural-crest derived DPSCs, which expressed
NSC markers such as Nestin and GFAP (Gronthos et al., 2000;
Chang et al., 2014). DPSCs were fully viable after 1 month post-
graft and capable of in vitro differentiating into mesenchymal
cell lineages and generating a dentin pulp-like tissue complex,
after in vivo subcutaneous transplantation (Gronthos et al.,
2002). Our first aim was to evaluate whether NeurocultTM,
a serum-devoid cell culture medium widely used to grow
adult NSCs and progenitors, would be also permissive for
the growth of DPSCs. For this purpose, we compared DPSC
cultures grown with the standard medium DMEM/FBS and
Neurocult proliferation medium. Interestingly, DPSCs cultured
with Neurocult maintained the expression of the brain-derived
neurotrophic factor (BDNF, Supplementary Figure S1), a
neurotrophin involved in neurogenesis and neuron survival
(Canals et al., 2004; Rossi et al., 2006). As Neurocult proliferation
medium is specially designed to generate neurospheres from
dissected and isolated brain neurogenic niches, we used control
cultures of NSCs from mouse hippocampi, by adapting the
protocol previously described (Pineda et al., 2013).
Both DPSC-derived dentospheres and NSC-derived
neurospheres were grown in human and mouse-specific
NeurocultTM proliferation supplemented media, respectively.
Once disaggregated from spheres, both NSCs and DPSCs were
induced to attach to the platting surface using laminin-coated
coverslips for 45 min, and they were immunostained against
the intermediate filament Nestin, a marker expressed by NSCs
both in vitro and in vivo (Reynolds and Weiss, 1992; Morshead
et al., 1994). Both DPSCs grown with DMEM + 10% FBS or
Neurocult proliferation media cells were positive for Nestin, as
well as NSCs (Figures 1A,B).
We evaluated the growth kinetics of DPSCs cultured either
using DMEM + 10% FBS or human specific Neurocult NS-A
proliferation medium. NSCs were grown with mouse specific
Neurocult proliferation medium. Human DPSCs showed a lower
proliferative index than murine NSCs (Figures 1C,D). The PD
rate in DPSCs showed no statistically significant differences
between Neurocult proliferation with respect to DMEM +
10% FBS, but it showed a faster growth of NSCs (p = 0.0556
and p = 0.0037, respectively; one-tailed Kruskal–Wallis test;
Figure 1C). However, the analysis of cumulative population
doubling (CPD) showed that both DMEM/FBS and Neurocult
DPSCs cultures had a parallel trend with steadily rising growth
kinetics after consecutive passages without reaching significant
differences until P3, where differences began to emerge between
both conditions (p = 0.0273, one-tailed Kruskal–Wallis test;
Figure 1D). It is noteworthy that DPSCs cultured using
DMEM + 10% FBS grew attached to the flask plastic surface,
even without any coating. Meanwhile, DPSCs in Neurocult
proliferation had a progressively slower growth, and generated
free-floating dentospheres during all the successive passages, as
normally NSCs do.
Triple immunofluorescence analysis was performed against
GFAP, Nestin, and S100β at 3 days post seeding for high
proliferating NSCs, and at 7 days for the more slowly growing
human DPSCs in Neurocult proliferation medium. Both cultures
showed comparable proportions of label-positive cells in DPSCs
and NSCs, for each of the three tested markers (Figure 2).
Nestin-GFAP coexpression is a long-known and widely reported
marker profile characteristic of NSCs (Davidson, 1994; Pineda
et al., 2013), which was also found in DPSCs cultures using
neuronal inductive media (Chang et al., 2014). The mature
astrocytic marker S100β, whose expression in GFAP-expressing
cells coincides with the loss of their NSCs potential (Raponi et al.,
2007), could also be detected in a minority of cells, both in DPSC
and NSC cultures. We determined that all human DPSCs cells
were Nestin positive, in agreement with the results published
by Chang et al. (2014) with a proportion of 69 ± 34% GFAP
and 24 ± 17% S100β positive cells (Figures 2A,A’); 96 ± 18%
murine NSCs grown with Neurocult proliferation media were
Nestin-positive with a proportion of 52 ± 12% GFAP and
35 ± 10% S100β positive cells (Figures 2B,B’). Thus, DPSCs and
NSCs grown in Neurocult proliferation media contained similar
proportions of cells expressing NSC markers, and putatively
astrocyte-committed S100β positive cells.
DPSCs Grown Using Neurocult NS-A
Proliferation Medium Increased the
Expression of the Endothelial
Marker CD31
Stem cells from human exfoliated deciduous teeth and DPSCs
grown in the presence of serum are able to differentiate into
endothelial vasculature (d’Aquino et al., 2007; Sakai et al., 2010;
Zhang D. et al., 2016), but it remained unknown whether
this capability was dependent or not on the presence of fetal
serum. Given that DPSCs grown in serum-free Neurocult
proliferation expressed the stem cell marker Nestin, which has
also been reported to be a marker of proliferative endothelial
cell progenitors (Suzuki et al., 2010), we wondered if serum-
free Neurocult proliferaton would also be permissive for the
generation of endothelial cells by detecting the expression of
CD31 and VEGF, which are both markers of endothelial cells
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FIGURE 1 | Human DPSCs grown in Neurocult proliferation culture media generate dentospheres similar to neurospheres from murine neural stem cells (NSCs).
(A) Human DPSCs seeded in standard culture DMEM + 10% FBS acquire a flat morphology and adhere to the flask surface. However, when cultured with Neurocult
proliferation media, DPSCs start to grow forming free-floating dentospheres. (B) Control neurospheres of murine NSCs. All cells are positive for the neural
stem/progenitor marker Nestin. (C) Population doubling rates for human DPSCs grown either with DMEM + 10% FBS or Neurocult proliferation compared with
murine NSCs. (D) Cumulative population doubling (CPD) of DPSCs seeded in standard culture DMEM+10%FBS or Neurocult proliferation media and NSCs cultured
in Neurocult proliferation media. All different cell culture conditions were assessed in parallel (n = 3 for each) for a total of four passages and non-parametric
Kruskal–Wallis with post hoc test was used (mean ± SD of two independent experiments ∗p < 0.05, ∗∗p < 0.01, and ∗∗∗p < 0.001). Scale bar 75 µm.
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FIGURE 2 | Human DPSCs grown in Neurocult proliferation share neural
stem/progenitor markers with murine NSCs. (A,A’) Human DPSCs were
allowed to grow for 7 days in laminin-coated wells in the presence of
Neurocult proliferation media are Nestin positive and also express astroglial
markers GFAP and S100ß (n = 230). (B,B’) Murine NSCs grown for 3 days (to
avoid confluency) in the same culture conditions also express these astroglial
markers in similar proportion (n = 242). Mean ± SEM of three independent
experiments. Scale bar 75 µm.
(Wong and Dorovini-Zis, 1996; Maharaj et al., 2006). Q-PCR
of CD31 mRNA expression in DPSCs cultured with Neurocult
proliferation showed an increase of up to several orders of
magnitude (249 ± 172 fold-increase of expression) with respect
to cultures with DMEM 10% FBS (p = 0.0286; Mann Whitney
test, Figure 3A). To confirm this result, in a next step, we
decided to perform an immunofluorescence analysis for the
endothelial marker CD31 followed by a confocal orthogonal
cell reconstruction on laminin-coated slides, in both DPSCs
grown in DMEM + 10% FBS and Neurocult proliferation
conditions. Interestingly, murine NSCs derived from neurogenic
niches were completely negative for CD31 staining (Figure 3B,
right panel) and did not integrate into murine vasculature after
intracerebral graft in consanguine mice, although they showed
some projecting contacts to the brain vasculature, as previously
described (Pineda et al., 2013; Supplementary Figure S2).
By quantifying the fluorescence labeling intensity in images,
we determined that DPSCs grown in Neurocult proliferation
increased CD31 expression by 62 ± 10%, with respect to
DMEM+10% FBS (p = 0.0008, one-tailed Mann–Whitney test,
Figure 3C). It is known that laminin could induce a morphologic
differentiation of DPSC to endothelial cells (Lawley and Kubota,
1989). In order to exclude this possibility, we cultured DPSCs
without laminin as floating dentospheres and thereafter we run
a flow cytometry analysis by labeling the cells either with CD31-
FITC or the IgG control isotype. We detected an increase of up
to 26% of CD31-FITC positive cell population in DPSCs when
these cells were grown with Neurocult proliferation (Figure 3E).
In contrast, the flow cytometry analysis only gave a residual value
of 0.3% of CD31-positive DPSCs, when these cells were grown
in DMEM + 10% FBS (Figure 3D). In conclusion, our results
demonstrated that serum-free Neurocult proliferation medium
promoted the expression of the CD31 endothelial-cell marker
in DPSC cultures.
DPSCs Grown in Neurocult NS-A
Proliferation Medium Expressed the
VEGFR2 Receptor and Showed an
Increased ERK Pathway Activity
It was previously reported that ERK signaling and VEGFR
expression were required for endothelial differentiation of
SHEDs (Bento et al., 2013). Because DPSCs grown with
Neurocult proliferation expressed endothelial markers VEGF
and CD31, we checked by RT-PCR that DPSC cultures were
able to produce VEGF (Figure 4A). Next, we decided to
test the presence of VEGFR2 at mRNA and protein level
by Q-PCR and immunofluorescence. DPSCs cultured with
Neurocult proliferation showed 17 ± 10 fold-increase of
VEGFR2 mRNA with respect to cultures with DMEM 10% FBS
(p = 0.0002; one-tailed Mann–Whitney test, Figure 4A’) and
a corresponding increase of VEGFR2 immunostaining, which
presented a characteristic punctuated pattern. We quantified
immunolabeling intensity as the average of brighter pixels per
cell above the autofluorescence level (signal without primary
antibody). Neurocult proliferation DPSCs showed an average
of signal of 416 ± 79 bright pixels per cell with respect to
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FIGURE 3 | The endothelial marker CD31 is absent from NSCs whereas it can be enriched depending on the type of culture medium in DPSCs. (A) mRNA fold
change of the endothelial marker CD31 on DPSC cultures depending on the culture medium: DMEM/FBS vs. Neurocult proliferation. Axis represented as logarithmic
scale of CD31 expression from DPSC cultures of four different patients (mean ± SEM ∗p = 0.05, one-tailed Mann–Whitney test). (B) CD31 immunofluorescence and
orthogonal projection of DPSCs cultured with (left column) DMEM + 10% FBS or (middle column) Neurocult proliferation media NSC (right column) cultured with
Neurocult proliferation. Scale bars 10 µm. (C) Quantification of the immunolabeling signal intensity for CD31 (mean ± SEM of two independent experiments, n = 10
for DMEM 10% FBS and n = 10 for Neurocult proliferation, ∗∗∗p = 0.0008, one-tailed Mann–Whitney test), and (D) flow cytometry analysis for CD31 expression in
DPSC culture with DMEM+10%FBS or (E) Neurocult proliferation media (n = 10.000 events for each condition; ∗p = 0.05, one-tailed Mann–Whitney test).
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FIGURE 4 | DPSCs grown in Neurocult proliferation increase the expression of VEGFR2 and activate downstream ERK signaling. (A) RT-PCR detection for VEGF,
confirming its expression in both DMEM/FBS- and Neurocult-grown DPSCs. (A’) mRNA fold change of the endothelial marker VEGFR2 on DPSC cultures depending
upon the type of media: DMEM/FBS vs. Neurocult proliferation. Axis represented as logarithmic scale (mean ± SEM of three independent samples, ∗∗∗p = 0.0002,
one-tailed, Mann–Whitney test). (B) Immunofluorescence of VEGFR2 receptor staining for cells grown during 7 days with DMEM + 10% FBS (left) or Neurocult
proliferation (right). (B’) Control with no 1ary antibodies. Scale bar 10 µm. (C) Quantification of distribution of the average amount of bright pixels per cell
corresponding to VEGFR2 staining (n = 33 cells for DMEM + 10% FBS and n = 69 cells for Neurocult proliferation, ∗∗∗p = 0.0001, one-tailed, Mann–Whitney test).
(D) Immunofluorescence of phospho-ERK1/2 showed an increase of staining for cells grown with Neurocult proliferation medium, in contrast to DMEM + 10% FBS
DPSCs. Scale bar 10 µm. (D’) Control with no 1ary antibodies. Scale bar 10 µm. (E) Quantification of distribution of the average of bright pixels per cell
corresponding to phospho-ERK1/2 staining (n = 30 cells for DMEM + 10% FBS and n = 47 cells for Neurocult proliferation of three independent samples.
∗∗∗p = 0.0001, one-tailed, Mann–Whitney test).
Frontiers in Physiology | www.frontiersin.org 8 March 2019 | Volume 10 | Article 347
fphys-10-00347 March 26, 2019 Time: 18:47 # 9
Luzuriaga et al. hDPSCs Integrate Into Brain Vasculature
the average of 22 ± 3 bright pixels corresponding to cultures
with DMEM 10% FBS (p = 0.001, one-tailed Mann–Whitney
test, Figures 4B,C). Previous reports associated phosphorylation
of ERK1/2 protein to endothelial cell differentiation of SHED
(Bento et al., 2013), in addition to cell proliferation in
a large variety of cell types (Cobb, 1999). Interestingly,
DPSCs cultured with Neurocult proliferation clearly showed
an increased pERK staining (Figure 4D, middle) with respect
to DPSCs cultured with DMEM 10% FBS (Figure 4D, left).
No staining was found in controls without primary antibody
and a pixel signal threshold was set to determine and
subtract background (Figures 4B’,D’). Quantification of pERK
immunolabeling was made by averaging bright pixels per
cell above the autofluorescence level (signal without primary
antibody). Neurocult proliferation-grown DPSCs showed an
average of signal of 116 ± 61 bright pixels per cell with respect
to the average of 42 ± 23 bright pixels corresponding to cultures
with DMEM 10% FBS (p = 0.001, one-tailed Mann–Whitney
test, Figures 4D,E).
DPSCs Grown in Neurocult NS-A
Proliferation Presented a Concurrent
Activation of Proangiogenic ERK and
STAT3 Signaling Pathways
Previous reports demonstrated that endothelial cells
differentiation requires STAT3 phosphorylation by a VEGFR2
dependent mechanism (Chen et al., 2008). This VEGFR/STAT3
signaling pathway represents a point of convergence for many
angiogenic events (Chen et al., 2008). Once demonstrated
the increased presence of phospho-ERK and VEGFR2 in
Neurocult-grown DPSCs by PCR and immunofluorescence,
we assessed the levels of phospho-STAT3 with respect to total
STAT3, as well as phospho-ERK to total ERK by western blot
(WB). LSECs were used here as a positive control of mature
endothelial cells. As expected, free-floating DPSC dentospheres
cultured with Neurocult proliferation presented a higher ratio
of phospho-ERK/total ERK band intensity with respect to
standard DMEM + 10% FBS conditions [p = 0.04 (DMEM +
10% FBS vs Neurocult proliferation and p = 0.0273 (DMEM
+ 10% FBS vs LSEC, Figures 5A,A’)]. Interestingly, the same
also applied to the phospho-STAT3/total STAT3 levels, whose
ratio was increased specifically in DPSCs grown with Neurocult,
with respect to the rest of conditions (p = 0.05; one-tailed
Kruskal–Wallis test, Figures 5B,B’). Mature LSEC displayed a
strong activation of phospho-ERK signaling (Figure 5A) but not
of phospho-STAT3 signaling (Figure 5B). Thus, both p-ERK
and p-STAT3 signaling pathways were concurrently activated
exclusively in Neurocult-grown DPSCs.
Pharmacological STAT3 Inhibition
Abolished Endothelial Cell Induction in
Neurocult NS-A-Proliferation-
Grown DPSCs
A concurrent activation of ERK and STAT3 has been reported
to be necessary for the endothelial cell differentiation of
mesenchymal stem cells (Almalki and Agrawal, 2017). Given
the evidence that both pathways were active in Neurocult-
grown dentospheres, our next step was to disrupt phospho-ERK
and phospho-STAT3 signaling to assess whether this was also
required for the endothelial differentiation of DPSCs. Because it
had been reported that the simple inhibition of ERK basal activity
was sufficient to trigger apoptosis in cells cultured without serum
(Berra et al., 1998), we decided to focus on the blockage of the
STAT3 pathway on DPSCs cultured with Neurocult proliferation.
To this end, we chose to test the irreversible inhibitor Stattic
(Schust et al., 2006) on DPSCs that had been previously seeded
over laminin-coated coverslips. DPSCs cultured with Neurocult
proliferation were treated with the inhibitor Stattic for 72 h
at concentrations of 0 (control), 1, and 2.5 µM, as previously
described (Li et al., 2018). Despite an expected reduction in
the number of cells (Villalva et al., 2011), none of the cells
in culture in the presence of 1 and 2.5 µM Stattic expressed
human-CD31 positive staining (Figure 5C and Supplementary
Figures S4A–C). In conclusion, DPSCs grown using Neurocult
proliferation media increased concurrently the activity of both
ERK and STAT3 signaling pathways, and pharmacological
blockade of the latter abolished endothelial cell differentiation of
DPSCs in these conditions.
DPSCs Grown in Neurocult NS-A
Differentiation Medium Expressed
Neuronal and Astroglial Markers but Not
Endothelial CD31
Dental pulp stem cell cultures using Neurocult proliferation
media showed increased levels of VEGFR2, CD31+ phospho-
STAT3 and phospho-ERK. Similarly, a large body of literature
suggested that DPSCs were able to differentiate toward neuronal
and astroglial lineages in response to the appropriate stimuli
(Gronthos and Zannettino, 2008; Chang et al., 2014; Gervois
et al., 2015). Commercial Neurocult media can be optimized for
either stem cell expansion or adult neural cell differentiation, by
adding their respective culture supplements. Thus, the addition
of the differentiation kit supplement to Neurocult medium was
already known to induce neuronal and astroglial differentiation
of murine NSCs (Lanza, 2006; Belkind-Gerson et al., 2013). In
order to test the capacity of neural cell derivation out of DPSCs
as compared to NSCs (positive control), both NSCs and DPSCs
were grown in parallel with Neurocult differentiation media. Both
neurospheres and dentospheres were disaggregated and cells
were seeded in laminin-coated coverslips (in adherent form) for
7 consecutive days and then processed for immunofluorescence.
To assess neuronal lineage differentiation, we used DCX
and NeuN markers, both for immature and mature neurons,
respectively (Figure 6A). Differentiated NSCs showed a 40± 8%
of cells positive for DCX and 36 ± 9% for NeuN staining.
Differentiated NSC showed a characteristic neuron-like dendritic
morphology. On the other hand, when neuronal marker
expression was assessed in differentiated DPSCs, 39 ± 33% of
cells were positive for DCX, and 34 ± 13% of them showed
NeuN staining. However, the morphology of differentiated
DPSCs was completely different to differentiated NSCs, with long
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FIGURE 5 | DPSCs grown in Neurocult Proliferation activate both proangiogenic ERK and STAT3 signaling. Western blot membranes of 200,000 cells for each
condition showing (A) phospho-ERK1/2 and total ERK protein levels and (B) phospho-STAT3 and total STAT3 for DPSCs grown either with DMEM + 10% FBS (D)
or Neurocult proliferation (N) media. As a positive control, human liver sinusoidal endothelial cells (L, LSEC) were used. (A’) Quantification of phospho-ERK1/2
western blot in three different samples for each (D, N, L) condition [mean ± SEM; ∗p = 0.04 (D vs N) and ∗p = 0.0273 (D vs L); one-tailed Kruskal–Wallis test]. (B’)
Quantification of phospho-STAT3 [mean ± SEM; ∗p = 0.05 (D vs N); one-tailed Kruskal–Wallis test (full blotting of the gel is shown in Supplementary Material)]. (C)
Immunofluorescence and orthogonal projection of phospho-STAT3 and human CD31 label of DPSCs grown with Neurocult proliferation medium during 72 h using
different concentrations of the STAT3 inhibitor Stattic. At concentrations above 1 µM, Stattic abolishes the expression of CD31 in DPSCs. Scale bar 10 µm.
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FIGURE 6 | Human DPSCs are able to commit toward differentiation to neuronal-like and glial-like lineages. One week of culture of both human DPSCs and murine
(control) NSCs in Neurocult differentiation media is sufficient to induce them express markers for (A) neuronal lineage differentiation: doublecortin (DCX) and NeuN
staining, for immature and mature neurons, respectively, and (C) Astroglial lineage differentiation: glial fibrillary acidic protein (GFAP) and S-100β immunostaining, for
immature and mature astrocytes, respectively. (B,D) Graphs showing quantifications (mean ± SEM, n = 360 cells) of three independent experiments. (E) After 1
week of growth in neural differentiation conditions, both NSCs and DPSCs still express VEGF but downregulate CD31. (F) Quantification of the proportion of CD31
positive cells (n = 571). (G) Control with no 1ary antibodies. Scale bar 20 µm.
lamellipodia, and neither presence of dendrites nor any other
morphological feature that could make them resemble a neuron.
Despite a lack of morphological relationship, we did not find
any significant difference between the obtained rates of DCX or
NeuN positive cells, (p = 0.9701 and p = 0.8920, respectively;
Student’s t-test) depending on the type of source cells employed
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for differentiation: both DPSCs and NSCs gave rise to neuronal
marker-expressing cells in similar proportions (Figure 6B).
In addition, the proportions of cells that differentiated toward
astroglial lineage were also assessed. GFAP and S100β were used
as markers for immature and mature astrocytes, respectively.
It was found that 48 ± 15% of NSCs were positive for GFAP,
and 27 ± 7% for S100β staining. On the other hand, 35 ± 6%
of human DPSCs showed GFAP staining, and only 9 ± 7% of
differentiated DPSCs showed S100β staining. All the cells that
showed labeling for S100β also presented bipolar morphology.
Again, there were no statistically significant differences in
astroglial marker labeling proportions between differentiated
DPSCs and NSCs (p = 0.0764 Student’s t-test, Figures 6C,D).
Finally, we decided to check the generation of endothelial
cells in these conditions. Murine NSCs cultured using Neurocult
differentiation medium showed cytoplasmic VEGF staining but
were negative for the CD31 receptor. In the DPSC counterparts,
VEGF expression remained in the nucleus and a dramatic
reduction of CD31 labeling, with a scarce 5 ± 1% of CD31-
positive cells, were detected (Figures 6E,F). In conclusion,
the addition of proliferation supplement to Neurocult medium
induced human DPSCs, but not murine NSCs, to express
endothelial markers, whereas the addition of differentiation
supplement induced both DPSCs and NSCs to generate cells
which expressed both immature and mature neuronal and
astroglial markers in similar proportions, but with very different
morphologies, and a near-absence of expression of CD31.
DPSCs Grown in Neurocult NS-A
Proliferation in vitro and Grafted Into the
Mouse Brain in vivo Migrated and
Integrated Into Brain Vasculature
In view of the previous in vitro results showing DPSCs being
competent to differentiate into endothelial marker-expressing
cells using Neurocult NS-A proliferation medium, or switch
to neuronal and astroglial marker-expressing cells in Neurocult
NS-A differentiation medium, it was important to assess the
fate of DPSCs after their in vivo grafting into the brain.
Because no previous data existed about the generation of brain
neovasculature from DPSCs, we decided to carry out in vivo
intracranial cell grafts using DPSCs grown in Neurocult NS-A
proliferation medium. The athymic nude mice model was chosen
because it had been previously employed successfully to perform
intracranial grafts of human periodontal ligament-derived cells
(Bueno et al., 2013). Ten thousand human DPSC cells were
grafted as previously described (Pineda et al., 2013) varying
the stereotaxic coordinates to place cells intrahippocampally in
the dentate gyrus. Cell integration in brain tissue was assessed
after 30 days as previously described (Pineda et al., 2013) to
better assess the long-term viability of grafted DPSC-derived cells.
Human cells were identified using the specific anti-human Nestin
antibody as previously described (Jeitany et al., 2015).
Many grafted human cells were located within or very close
to blood vessels, which were labeled by laminin and VEGF
staining (Figure 7A). Interestingly, some of the small to medium
caliber blood vessels (arterioles and venules) appeared to be
mostly or exclusively generated by human DPSC-derived cells,
showing a very uniform and homogeneous labeling for human
proteins in coronal sections. Previous reports demonstrated that
Nestin protein is expressed in stem cells, but also in type-2
pericytes and proliferative endothelial cells, but absent in the
mature vasculature (Suzuki et al., 2010; Birbrair et al., 2014).
Interestingly, recent works using post-mortem human brain
tissue reported that human brain capillary-associated pericytes
express CD146 (Smyth et al., 2018). We wondered whether our
grafted human DPSCs would generate both CD146+ pericyte
and CD31+ endothelial cells which could integrate into the
murine vasculature. Co-immunolabeling using CD146 (pericyte)
or CD31 (endothelia) antibodies was performed together with the
human-specific Nestin antibody. By this approach, we detected
the presence of both human pericyte cells integrated in the
outer layers of the newly generated vasculature (Figure 7B)
and also endothelial cells facing the lumen of these human
DPSC-derived blood vessels (Figure 7C). To further validate the
presence of human endothelial cells derived from DPSC grafts,
we proceeded to label serial sections with a human-specific anti-
CD31 antibody. Again, we corroborated the presence of human
CD31 positive cells integrated into the host brain vasculature
of athymic nude mice at 1-month post graft (Figures 7D,E)
expressing the endothelial marker CD31 and a characteristic
flattened/elongated nuclear morphology, consistent with an
endothelial cell identity (Figures 7E,E’).
Close detail allowed us to determine an increased staining
of laminin and VEGF in blood vessels containing human cells,
with respect to blood vessels only containing the natural murine
vasculature (Figure 7A). Remarkably, all the vasculature that
contained human cells presented higher amounts of laminin
staining. This was quantified by choosing blood vessels of the
same caliber, and normalizing the level of intensity of murine
vasculature to 100 ± 12%. Thus, we determined that the
presence of human DPSC-derived cells within the blood vessel
raised the laminin-labeling intensity to 266 ± 33% (p < 0.0001
Student’s t-test, Figure 7D’). In summary, we demonstrated that
human DPSCs, grown with serum-free Neurocult proliferation
medium, were able to survive for 1-month and functionally
integrate within the brain vasculature of athymic nude mice,
expressing markers and morphological vasculature features with
characteristics of both pericyte and endothelial cells.
DISCUSSION
In this work, we reported for the first time that human DPSCs can
be grown long-term using serum-devoid Neurocult proliferation
media. In these conditions, both murine NSCs and human DPSCs
grew as spheres in suspension. Remarkably, the Neurocult NS-
A supplemented proliferation medium also increased largely the
generation of CD31-positive cells in DPSC cultures. These cells
integrated into host nude mice brain vasculature and acquired
endothelial cell characteristics, which could be clearly observed
after one month post-intracraneal graft. The newly formed
vasculature contained both pericyte and endothelial human cells,
and included many small to medium size blood vessels which
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FIGURE 7 | Human DPSCs survive after 1-month post graft into the brain of nude mice, expressing CD31 and VEGF and integrating into the host brain vasculature.
(A) Detail of human Nestin-positive DPSC-derived cells covering brain vasculature showed an increase in the staining for laminin and VEGF, suggesting de novo
vasculature formation. (B) Triple staining and orthogonal projection of human-Nestin, CD146, and DAPI shows human pericytes wrapping around the endothelial
murine (DAPI) cells (arrow). Scale bar 10 µm. (C) CD31 staining for both murine and human endothelial cells colocalizes with human Nestin-positive DPSC-derived
cells in some medium caliber blood vessels, showing their human origin. (D) A specific antibody for human-CD31 cells recognizes human DPSC-derived endothelial
cells within some of the blood vessels, which precisely correspond to the ones showing an increased laminin staining. Scale bar of images and orthogonal projection
10 µm. (D’) Quantification of laminin staining intensity for murine blood vessels and blood vessels containing human DPSC-derived endothelial cells (mean ± SEM
n = 30 and 35 blood vessels, respectively, for n = 4 grafted animals, ∗∗∗p = 0.0001, one-tailed Mann–Whitney test). Scale bar 20 µm. (E) 3D-reconstruction from a
10-µm thick cryostat slice showing human-CD31 endothelial cells in the inner wall of a blood-vessel decorated with laminin staining. Scale bar 5 µm. (E’) Close
detail of a human-CD31 positive cell showing the elongated nuclear morphology characteristic of endothelial cells (arrows). Scale bar 5 µm.
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expressed VEGF and had increased levels of laminin staining,
suggesting that grafted DPSCs favored a process of angiogenesis
and neovascularization. These results open a window to use the
DPSCs as a safe source of stem cells to generate endothelial
cells which integrate safely and contribute to the generation of
complete functional blood vessels into the host brain tissue, thus
potentially approaching innovative autologous cellular therapies.
To our knowledge, this is the first time in which DPSCs,
disaggregated from floating dentospheres grown in a serum-
free medium and grafted into the brain of immunosuppressed
mice, give rise to CD31-positive endothelial and CD146-positive
pericyte cells that can integrate into the host brain vasculature,
promoting de novo generation of new blood vessels containing
both endothelial and mural layers, within brain tissue. Previous
works using myocardial infarction model showed that DPSC
grafts were able to induce heart angiogenesis (Gandia et al., 2008).
Finally, other studies also reported a positive effect of DPSC
transplants on the recovery of sensorimotor brain functions after
stroke, which was attributed to diverse paracrine mechanisms
(Leong et al., 2012). However, in all these cases, DPSCs had been
grown in the presence of 10–20% fetal serum.
Previous reports described the capability of sorted DPSCs
grown in the presence of 10% fetal serum to differentiate
synergistically into osteoblasts and endotheliocytes mantaining
their fate when grafted subcutaneously in vivo (d’Aquino et al.,
2007). However, woven bone chips produced in vitro were
necessary, contrary to the present results where no bone was
generated after the in vivo DPSC brain graft. Remarkably,
it is known that at a 10–20% concentration, FBS can also
stimulate osteoblastic differentiation which in turn promotes the
generation of neovasculature (Laino et al., 2006), although bone
production is not desirable in the brain. FBS is usually added to
the culture medium to support DPSC survival and facilitate cell
expansion. This addition imposes at least two big caveats that
make serum use very impractical to apply to DPSC transplants to
treat brain lesions: (i) the non-desired osteoblastic differentiation
of the grafted cells and (ii) the stem cell incorporation and
contamination of xenogenic FBS that might cause a dangerous
brain inflammatory reaction (Gregory et al., 2006). In the
present work, we overcome these limitations using a serum-free
culture medium compatible with the intracranial graft of human
DPSCs. Neurocult serum-free culture media are routinely used
for in vitro amplification of NSCs and progenitors and do not
cause graft rejection.
Very few works in the literature describe the culture of
dental stem cells with no fetal serum in none of the culture
phases: expansion and/or differentiation. Hirata et al. (2010)
demonstrated for the first time the possibility to maintain
stem cells from deciduous or wisdom tooth pulp cells without
the need of serum, but without further characterization. Also,
Bonnamain et al. (2013) were able to culture human pulp
stem cells in a serum-free supplemented basal medium, but
they reported a 30% of efficiency to generate non-adherent
spheroid-like morphologies (Morsczeck et al., 2010). By a
protocol using serum-free Neurocult medium supplemented
with proliferation kit and with EGF/FGF2, heparin and B27
without vitamin A, we achieved a near 100% success in
dentosphere generation in human DPSC cultures. Previous
literature about DPSC intracranial grafts had mainly focused on
searching for neuronal fates of the transplanted cells (Arthur
et al., 2008; Chang et al., 2014). Our work is the first to
report that non-engineered or non-genetically modified human
DPSCs can differentiate and integrate into mouse intracerebral
vasculature, promoting neovasculogenesis. This approximation
for cell expansion without the use of serum is an important
aspect for future translational therapies, excluding the potential
variability and risk of contamination by xenogenic FBS or
genetical manipulation. These results are of major interest
because no report exists to date which is focused on obtaining
endothelial cells and fully blood vessels starting from DPSCs and
using a serum-free protocol. Previous works were focused on
the neural differentiation of DPSCs in serum-free media (Widera
et al., 2007; Hirata et al., 2010; Bonnamain et al., 2013), or the
obtention of endothelial vascular cells using 10% FBS (Weiss
et al., 1990; d’Aquino et al., 2007) but none of them addressed
the issue of endothelial cell generation out of human DPSCs in
the total absence of serum. Non-human vascular cells had already
been succesfully cultured without the need of serum, although the
reported protocol was not optimized for human cells (Weiss et al.,
1990; Gorfien et al., 1993).
Nestin expression had been related to de novo formation of
vasculature (Suzuki et al., 2010). The coexpression of Nestin and
VEGF in grafted human DPSC-derived cells constitutes a solid
evidence of neoangiogenesis (Ferrara et al., 2003). Altogether,
Nestin/VEGF and/or CD31 human positive cells integrated into
the host vasculature with increased laminin staining are the
hallmarks that led us to advocate for de novo angiogenesis
(Nguyen et al., 2000; Malinda et al., 2008). We could speculate
that grafts of human DPSC cultured with Neurocult proliferation
media could favor a rejuvenation-like benefitial effect in brain
vasculature, because laminin is one of the main extracellular
matrix (ECM) components that progressively decreases up to
50% during the aging process (Gavazzi et al., 1995). Interestingly,
there is also an increase of vascular TGF-β during aging, which
has been reported to induce quiescence of neurogenic niches
(Pineda et al., 2013). Furthermore, laminin has been described to
be able to downregulate TGF-β, at least in epithelial cells (Streuli
et al., 1993). Thus, the increase of vascular laminin could again
constitute a rejuvenation-like stimulus through TGF-β. From a
point of view of biological or therapeutic interest, the increase
of vascular laminin observed in blood vessels containing DPSC-
derived cells could also have beneficial effects in the case of
neurodegenerative illnesses such as Alzheimer’s disease. It has
been reported that laminin is able to induce depolymerization
of amyloid αβ fibrils reducing the toxic effects of amyloid
peptides (Bronfman et al., 1996; Morgan and Inestrosa, 2001).
In cerebro-vascular accident models such as focal cerebral
ischemia, a degradation of the microvascular matrix of collagen,
perlecan and laminin has been reported (Fukuda et al., 2004).
In addition, variations of laminin levels during CNS injury have
been associated to an attempt to revascularize and oxygenate
the tissue (Fukuda et al., 2004; Ji and Tsirka, 2012). In other
ischemia models such as the middle cerebral artery occlusion
(MCAO), the ECM, and secreted factors such as VEGF are
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involved in the progressive recovery (Fukuda et al., 2004). Per se,
the use of DPSCs as a source of cells secreting neuroprotective
BNDF also brings an enormous potential for vasculogenesis
(Alomari et al., 2015) and neuroprotective therapies (Canals
et al., 2004; Pineda et al., 2005). Interestingly, we showed that
DPSCs cultured with Neurocult proliferation media maintained
BDNF expression. This could provide an improvement for
neurotrophic therapy in cerebrovascular accidents such as stroke
(Schäbitz et al., 2007), a condition which carries a strong
economic and social burden (Di Carlo, 2009) together with
an increased probability of future dementia (Pendlebury et al.,
2019). Furthermore, from a perspective of cellular therapy, brain-
grafted DPSCs could compensate the reduction in proliferation of
vascular endothelial progenitor cells which is observed after acute
ischemic cerebrovascular events (Blum et al., 2019). However,
all these discussed applications are beyond the scope of this
manuscript, but warrant further investigations.
Interestingly, DPSC expansion in Neurocult proliferation
culture media increased the proportion of cells expressing the
endothelial markers VEGF and CD31, with respect to neural-
differentiated or DMEM/FBS grown DPSC cultures. We also
attempted to shed light on the involved mechanism(s) for this
effect. It has been reported that constitutive STAT3 activity
upregulated VEFG expression (Niu et al., 2002). In agreement,
our results clearly showed that Neurocult proliferation medium
actually activated the VEGFR/STAT3 signaling pathway in
DPSCs, which is fundamental for endothelial cell differentiation.
Indeed, we observed a concurrent increase of both phospho-
STAT3 and phosphor-ERK levels in Neurocult-grown DPSCs,
and this dual concurrent signaling has been associated not only
to the activation of endothelial cells (Chen et al., 2008), but
also to the ability of mesenchymal stem cells to differentiate
to endothelial cell phenotypes (Almalki and Agrawal, 2017).
Interestingly, selective inhibition of phospho-STAT3 signaling
using the chemical compound Stattic was just enough to
abolish the endothelial induction effect of Neurocult proliferation
medium in DPSCs. This result highlighted the importance
of downstream signaling events to control DPSC endothelial
differentiation. Stattic was already known to abrogate both
cancer stem cells proliferation (Villalva et al., 2011) and tumor
angiogenesis (Niu et al., 2002). Meanwhile, phospho-ERK had
been long regarded to play a role in the differentiation of
endothelial cells into angiogenic vessels (Xu et al., 2008).
Other dental stem cell types such as SHEDs were also
reported to be able to differentiate to neural and astroglial
lineages (Miura et al., 2003) and endothelium (Sakai et al., 2010;
Bento et al., 2013). Interestingly, the expression of VEGF by
SHEDs was required to induce cellular expression of endothelial
differentiation markers such as vascular endothelial growth factor
receptor-2 (VEGFR2), CD31 (PECAM-1), and VE-Cadherin
(Sakai et al., 2010). Similar results have been published with
stem cells from the apical papilla (SCAPs) or DPSC previously
expanded with α-MEM (d’Aquino et al., 2007; Hilkens et al.,
2017). However, the aforementioned studies relied on the
presence of 10% FBS in the cell culture medium, and/or the use
of hydroxyapatite/tricalcium phosphate 3D scaffolds to show the
successful formation of vascularized tissue (Sakai et al., 2010).
Our results demonstrate that a serum-free medium designed to
culture NSCs is also permissive to grow endothelial cells derived
from human DPSC cultures. In our comparative study, we found
that murine NSCs in Neurocult proliferation medium presented
high levels of phospho-ERK signaling but low levels of phospho-
STAT3 signaling, as opposed to human DPSCs grown in the
same conditions, which activated both pathways simultaneously.
Interestingly, murine NSC were neither able to differentiate
toward endothelial cells in the same medium, nor to give rise to
functional blood vessels after their graft in vivo. Some works have
reported the need of estradiol for the endothelial differentiation
of neural stem/progenitor cells (Sekiguchi et al., 2013), which
might somehow affect these signaling pahways.
CONCLUSION
In the present work, we show that DPSCs cultured using
NeurocultTM NS-A proliferation supplemented medium
increase CD31 and VEGFR2 expression and a concurrent
activation of proangiogenic ERK and STAT3 signaling pathways.
Pharmacological inhibition of STAT3 is sufficient to impair
DPSC differentiation to endothelial cell fate. In vivo approach
by intrahippocampal graft of DPSCs previously cultured using
Neurocult proliferation medium demonstrated that human
DPSC-derived endothelial cells migrated and integrated into the
host brain vasculature, contrary to murine NSCs. Our results
highlight the potential of non-genetically modified human
DPSCs grown in serum-free media for cell therapy in future
therapeutical approaches for brain vasculopaties. This advance is
of utmost importance because the applications of DPSCs in cell
therapy have been so far largely limited by the use of fetal serum
in conventional DPSC cultures.
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